AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28

Authors: SOUKOP M
Citation: M. Soukop, ADVERSE REACTIONS TO ANTINAUSEANTS IN COMMON USE IN THE UK, Adverse drug reactions and toxicological reviews, 17(2-3), 1998, pp. 91-113

Authors: EATOCK MM ANTHONY DA WILSON P SOUKOP M SMITH M EVANS TRJ
Citation: Mm. Eatock et al., PRELIMINARY-RESULTS OF A DOSE-FINDING STUDY OF TOMUDEX WITH CISPLATINAND EPIRUBICIN AS FIRST-LINE THERAPY FOR METASTATIC OR UNRESECTABLE GASTRIC AND ESOPHAGEAL ADENOCARCINOMA, Annals of oncology, 9, 1998, pp. 235-235

Authors: HAYNES BP GRIMSHAW RM GRIGGS LJ HARDCASTLE I NUTLEY BP JARMAN M JOHNSTON SRD TWELVES CJR SOUKOP M REA DW HOWELL A JONES A COOMBES RC
Citation: Bp. Haynes et al., PHARMACOKINETIOS OF IDOXIFENE AND TAMOXIFEN IN A RANDOMIZED PHASE-II TRIAL IN BREAST-CANCER PATIENTS WHO HAVE RELAPSED ON TAMOXIFEN, Annals of oncology, 9, 1998, pp. 679-679

Authors: CASSIDY J PAUL J SOUKOP M HABESHAW T REED NS PARKIN D KAYE SB
Citation: J. Cassidy et al., CLINICAL-TRIALS OF NIMODIPINE AS A POTENTIAL NEUROPROTECTOR IN OVARIAN-CANCER PATIENTS TREATED WITH CISPLATIN, Cancer chemotherapy and pharmacology, 41(2), 1998, pp. 161-166

Authors: BRANKIN E GALLAGHER A SOUKOP M
Citation: E. Brankin et al., HYPOGLYCEMIA ASSOCIATED WITH FORMESTANE TREATMENT, BMJ. British medical journal, 314(7084), 1997, pp. 869-869

Authors: LOPEZ RI PAUL J ATKINSON R SOUKOP M KITCHENER H FULLERTON W DUNCAN I KENNEDY J DAVIS J MACLEAN A CASSIDY J PYPER E KAYE SB
Citation: Ri. Lopez et al., PROGNOSTIC FACTOR-ANALYSIS, FOR PATIENTS WITH NO EVIDENCE OF DISEASE AFTER INITIAL CHEMOTHERAPY FOR ADVANCED EPITHELIAL OVARIAN-CARCINOMA, International journal of gynecological cancer, 6(1), 1996, pp. 8-14

Authors: DALY M COWIE VJ DAVIS JA HABESHAW T JUNOR E PAUL J PYPER E REED NS SOUKOP M YOSEF H SYMONDS RP
Citation: M. Daly et al., A SHORT AND INTENSIVE SINGLE-AGENT CISPLATIN REGIMEN FOR RECURRENT CARCINOMA OF THE UTERINE CERVIX, International journal of gynecological cancer, 6(1), 1996, pp. 61-67

Authors: HUGHES MJ KERR DJ CASSIDY J SOUKOP M MCGREGOR K BLACKBURN N YOSEF H KAYE SB
Citation: Mj. Hughes et al., A PILOT-STUDY OF COMBINATION THERAPY WITH INTERFERON-ALPHA-2A AND 5-FLUOROURACIL IN METASTATIC CARCINOID AND MALIGNANT ENDOCRINE PANCREATICTUMORS, Annals of oncology, 7(2), 1996, pp. 208-210

Authors: KAYE SB PAUL J CASSIDY J LEWIS CR DUNCAN ID GORDON HK KITCHENER HC CRUICKSHANK DJ ATKINSON RJ SOUKOP M RANKIN EM DAVIS JA REED NS CRAWFORD SM MACLEAN A PARKIN D SARKAR TK KENNEDY J SYMONDS RP
Citation: Sb. Kaye et al., MATURE RESULTS OF A RANDOMIZED TRIAL OF 2 DOSES OF CISPLATIN FOR THE TREATMENT OF OVARIAN-CANCER, Journal of clinical oncology, 14(7), 1996, pp. 2113-2119

Authors: EATOCK MM CARLIN W DUNLOP DJ SOUKOP M WATSON DG
Citation: Mm. Eatock et al., BIOAVAILABILITY OF SUBCUTANEOUS 5-FLUOROURACIL - A CASE-REPORT, Cancer chemotherapy and pharmacology, 38(1), 1996, pp. 110-112

Authors: SOUKOP M
Citation: M. Soukop, MANAGEMENT OF CYCLOPHOSPHAMIDE-INDUCED EMESIS OVER REPEAT COURSES, Oncology, 53, 1996, pp. 39-45

Authors: EATOCK M COOK G FRANKLIN IM TANSEY P SOUKOP M DUNLOP D
Citation: M. Eatock et al., PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) RESCUE FOLLOWING HIGH-DOSE CHEMOTHERAPY IN BREAST-CANCER - SATISFACTORY EARLY HEMATOPOIETIC RECONSTITUTION, British Journal of Cancer, 73(8), 1996, pp. 25-25

Authors: BRANKIN E GALLACHER SJ BESSENT R SOUKOP M BOYLE IT
Citation: E. Brankin et al., BONE-MINERAL DENSITY IN ADULTS WITH LYMPHOMA AND THE EFFECTS OF TREATMENT, British Journal of Cancer, 73(8), 1996, pp. 112-112

Authors: RUSTIN GJS CRAWFORD SM COLEMAN RE LAMBERT J LEDERMANN JA SOUKOP M KARP S PHILLIPS RH HABBOUBI N MEELY K
Citation: Gjs. Rustin et al., TRIAL OF ORAL HEXALEN FOR RELAPSED OVARIAN-CARCINOMA [OV CA] - COMPARISON OF CA125 AND EORTC RESPONSE DEFINITIONS/, European journal of cancer, 31A, 1995, pp. 513-513

Authors: TYRRELL CT BRUNING PF MAYLEVIN F ROSE C MAURIAC L SOUKOP M FORD JM
Citation: Ct. Tyrrell et al., PAMIDRONATE INFUSIONS AS SINGLE-AGENT THERAPY FOR BONE METASTASES - APHASE-II TRIAL IN PATIENTS WITH BREAST-CANCER, European journal of cancer, 31A(12), 1995, pp. 1976-1980

Authors: ADAMS M SOUKOP M BARLEY V YOSEF H ANDERSON N BOESEN E TRASK CW RUFENACHT E DEBRUIJN KM
Citation: M. Adams et al., TROPISETRON ALONE OR IN COMBINATION WITH DEXAMETHASONE FOR THE PREVENTION AND TREATMENT OF EMESIS INDUCED BY NON-CISPLATIN CHEMOTHERAPY - ARANDOMIZED TRIAL, Anti-cancer drugs, 6(4), 1995, pp. 514-521

Authors: SRIDHAR M JEFFERS M BRANKIN E SOUKOP M BANHAM S
Citation: M. Sridhar et al., WHEEZE IN A HEART-TRANSPLANT PATIENT WITH LYMPHOMA, Postgraduate medical journal, 71(836), 1995, pp. 375-377

Authors: WOLL PJ CROWTHER D JOHNSON PWM SOUKOP M HARPER PG HARRIS M BRAMPTON MH NEWLANDS ES
Citation: Pj. Woll et al., PHASE-II TRIAL OF TEMOZOLOMIDE IN LOW-GRADE NON-HODGKINS-LYMPHOMA, British Journal of Cancer, 72(1), 1995, pp. 183-184

Authors: SOUKOP M
Citation: M. Soukop, CLINICAL-EXPERIENCE WITH INTRAVENOUS GRANISETRON, Anti-cancer drugs, 5(3), 1994, pp. 281-286

Authors: GOEDHALS L JORDAAN JP KAYE SB ARMAND JP VEENHOF CHN FALKSON G SOUKOP M SCHNEIDER M OBERLING F BUI BN ROCHE H ADENIS L CATY A BLIJHAM GH DEWEWEIRE A COIFFIER B SOTTO JJ VANHEUKELOM LS TAGNON A SLEE PHTJ KROEKS MVAM RAVEZ P CUPISSOL D KEIZER HJ BRUNNER K CALVERT AH YERNAULT JC LIBERT P BROHEE D
Citation: L. Goedhals et al., A DOSE-FINDING STUDY OF GRANISETRON, A NOVEL ANTIEMETIC, IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN, Supportive care in cancer, 2(3), 1994, pp. 177-183

Authors: WISHART GC BISSETT D PAUL J JODRELL D HARNETT A HABESHAW T KERR DJ MACHAM MA SOUKOP M LEONARD RCF KNEPIL J KAYE SB
Citation: Gc. Wishart et al., QUINIDINE AS A RESISTANCE MODULATOR OF EPIRUBICIN IN ADVANCED BREAST-CANCER - MATURE RESULTS OF A PLACEBO-CONTROLLED RANDOMIZED TRIAL, Journal of clinical oncology, 12(9), 1994, pp. 1771-1777

Authors: PRESCOTT RJ LEONARD RCF ALLAN NC ANGUS B BARRETT A DAS SN DAWSON AA HEPPLESTON A LESSELLS AM LUCIE NP LUCRAFT HH MACKIE MJ MACLAREN KS MATHESON LM PARKER AC PROCTOR SJ SARKAR TK SOUKOP M STEWARD WP WHITE JM
Citation: Rj. Prescott et al., PILOT-STUDY AND RANDOMIZED TRIAL OF MITOXANTRONE AND IFOSFAMIDE FOR RELAPSED NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 11(1-2), 1993, pp. 111-114

Authors: CAMERON DA LEONARD RCF MAO JH PRESCOTT RJ ALLAN NC BARRETT A DAS SN DAWSON AA HEPPLESTON A LENNARD AL LEONARD RCF LESSELLS AM LUCIE NP LUCRAFT HH MACKIE MJ MACLAREN KS MATHESON LM PARKER AC PRESCOTT RJ PROCTOR SJ ROBERTSON AG SARKAR TK SOUKOP M STEWARD WP TANSEY PJ WHITE JM
Citation: Da. Cameron et al., IDENTIFICATION OF PROGNOSTIC GROUPS IN FOLLICULAR LYMPHOMA, Leukemia & lymphoma, 10(1-2), 1993, pp. 89-99

Authors: AAPRO M PIGUET D GIGER K BAUER J HAEFLIGER JM BREMER K CALS L CATTAN A CLAVEL M CZYGAN P DEARNALEY D DIEHL V HARJUNG M HARPER P ILLIGER H KAYE S KEIZER HJ KERBRAT P KONIG HJ MONCUQUET P DEBESANCON C NAMER M NOBEL A NORTIER JWR OBERLING F PLAGNE R REICHLE A RIVIERE A SOUKOP M VEENHOF CHN ZYLBERAIT D HUNTER B
Citation: M. Aapro et al., THE ANTIEMETIC EFFICACY AND SAFETY OF GRANISETRON COMPARED WITH METOCLOPRAMIDE PLUS DEXAMETHASONE IN PATIENTS RECEIVING FRACTIONATED CHEMOTHERAPY OVER 5 DAYS, Journal of cancer research and clinical oncology, 119(9), 1993, pp. 555-559

Authors: FORREST E GALLACHER SJ HADLEY D SOUKOP M BOYLE IT
Citation: E. Forrest et al., CENTRAL-NERVOUS-SYSTEM HISTIOCYTOSIS-X - IMAGING AND RESPONSES TO CHEMOTHERAPY, Scottish Medical Journal, 38(5), 1993, pp. 148-149
Risultati: 1-25 | 26-28